-
Retinitis Pigmentosa Market In 2029
19 Dec 2025 05:17 GMT
… pharmacy for retinitis pigmentosa market, the electroretinogram retinitis pigmentosa market, and the retinitis pigmentosa and vitamin …
-
Retinitis Pigmentosa Market Competition Analysis 2025: How Players Are Shaping Growth
18 Dec 2025 05:51 GMT
… the Market?
• Advancements in retinitis pigmentosa treatment to accelerate research, … February 2025) accelerates research into retinitis pigmentosa (RP), a progressive retinal … com/report/retinitis-pigmentosa-global-market-report
The Business …
-
Beacon Therapeutics Treats First Patient in LANDSCAPE Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP)
16 Dec 2025 13:00 GMT
… of patients with X-linked retinitis pigmentosa (XLRP). “Following the completion of … caused by mutations to the retinitis pigmentosa GTPase regulator (RPGR) gene and … diseases such as X-linked retinitis pigmentosa (XLRP) and geographic atrophy. Beacon …
-
Human-only RPGR isoform and Rho/ROCK1 inhibitor as approach for X-linked retinitis pigmentosa
12 Nov 2025 00:34 GMT
… turnover known to occur in retinitis pigmentosa.
BioWorld Science Ocular
-
<![CDATA[Q&A: Stephen Tsang discusses outcomes in retinitis pigmentosa and Stargardt trials]]>
10 Nov 2025 23:17 GMT
… optogenetic therapy for patients with retinitis pigmentosa and Stargardt disease at the … retinal diseases. In patients with retinitis pigmentosa, vision gains averaged about … optogenetic therapy in adults with retinitis pigmentosa and Stargardt disease, and …
-
MCO-010 shows long-term safety in retinitis pigmentosa
07 Nov 2025 22:24 GMT
… of life in patients with retinitis pigmentosa after a single intravitreal injection … , followed 10 patients with advanced retinitis pigmentosa (RP) over 5 years after … .
Perspective
Back to Top
Treating retinitis pigmentosa (RP) with gene therapy seems …
-
<![CDATA[Nanoscope Therapeutics releases positive long-term EXTEND safety data in retinitis pigmentosa]]>
07 Nov 2025 01:12 GMT
… followed 10 patients with advanced retinitis pigmentosa (RP) who had previously received … (NCT04945772) evaluating MCO-010 in retinitis pigmentosa (RP).2
According to the …
-
Nanoscope Therapeutics Presents 5-Year Safety Data for MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
06 Nov 2025 15:52 GMT
… treatment for patients with advanced retinitis pigmentosa (RP). The findings support the …
-
SparingVision Doses First Patient in NYRVANA Trial Evaluating SPVN20 for Retinitis Pigmentosa
01 Nov 2025 22:41 GMT
… therapy for patients with advanced retinitis pigmentosa (RP). This milestone marks a …
-
<![CDATA[SparingVision begins dosing patients with retinitis pigmentosa in NYRVANA clinical trial]]>
30 Oct 2025 13:11 GMT
… SPVN20 in patients with advanced retinitis pigmentosa (RP).
NYRVANA is the first …
About
© 1995-2025